{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:35:39Z","timestamp":1793136939888,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,7,31]],"date-time":"2007-07-31T00:00:00Z","timestamp":1185840000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2007,9,10]]},"DOI":"10.1007\/s10557-007-6035-1","type":"journal-article","created":{"date-parts":[[2007,7,30]],"date-time":"2007-07-30T15:21:01Z","timestamp":1185808861000},"page":"227-233","source":"Crossref","is-referenced-by-count":302,"title":["Necrostatin: A Potentially Novel Cardioprotective Agent?"],"prefix":"10.1007","volume":"21","author":[{"given":"Christopher C. T.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean M.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiang Y.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Simpkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S.","family":"Hothersall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek M.","family":"Yellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,7,31]]},"reference":[{"key":"6035_CR1","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s003950050066","volume":"93","author":"B Freude","year":"1998","unstructured":"Freude B, Masters TN, Kostin S, Robicsek F, Schaper J. Cardiomyocyte apoptosis in acute and chronic conditions. Basic Res Cardiol 1998;93:85\u20139.","journal-title":"Basic Res Cardiol"},{"key":"6035_CR2","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0008-6363(03)00533-9","volume":"61","author":"AP Halestrap","year":"2004","unstructured":"Halestrap AP, Clarke SJ, Javadov SA. Mitochondrial permeability transition pore opening during myocardial reperfusion\u2014a target for cardioprotection. Cardiovasc Res 2004;61:372\u201385.","journal-title":"Cardiovasc Res"},{"key":"6035_CR3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cardiores.2004.04.011","volume":"63","author":"DJ Hausenloy","year":"2003","unstructured":"Hausenloy DJ, Duchen MR, Yellon DM. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc Res 2003;63:305\u201312.","journal-title":"Cardiovasc Res"},{"key":"6035_CR4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cardiores.2003.09.024","volume":"61","author":"DJ Hausenloy","year":"2004","unstructured":"Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res 2004;61:448\u201360.","journal-title":"Cardiovasc Res"},{"key":"6035_CR5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/01.fjc.0000154376.82445.06","volume":"45","author":"CA Efthymiou","year":"2005","unstructured":"Efthymiou CA, Mocanu MM, Yellon DM. Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signaling. J Cardiovasc Pharmacol 2005;45:247\u201352.","journal-title":"J Cardiovasc Pharmacol"},{"key":"6035_CR6","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/01.fjc.0000188365.07635.57","volume":"46","author":"AM Wynne","year":"2005","unstructured":"Wynne AM, Mocanu MM, Yellon DM. Pioglitazone mimics preconditioning in the isolated perfused rat heart: a role for the prosurvival kinases PI3K and p42\/44 MAPK. J Cardiovasc Pharmacol 2005;46:817\u201322.","journal-title":"J Cardiovasc Pharmacol"},{"key":"6035_CR7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/sj.bjp.0704548","volume":"135","author":"GF Baxter","year":"2002","unstructured":"Baxter GF, Ebrahim Z. Role of bradykinin in preconditioning and protection of the ischaemic myocardium. Br J Pharmacol 2002;135:843\u201354.","journal-title":"Br J Pharmacol"},{"key":"6035_CR8","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/hh2401.101385","volume":"89","author":"AK Jonassen","year":"2001","unstructured":"Jonassen AK, Sack MN, Mjos OD, Yellon DM. Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling. Circ Res 2001;89:1191\u20138.","journal-title":"Circ Res"},{"key":"6035_CR9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00395-005-0537-4","volume":"100","author":"AJ Bullard","year":"2005","unstructured":"Bullard AJ, Govewalla P, Yellon DM. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo. Basic Res Cardiol 2005;100:397\u2013403.","journal-title":"Basic Res Cardiol"},{"key":"6035_CR10","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2337\/diabetes.54.1.146","volume":"54","author":"AK Bose","year":"2005","unstructured":"Bose AK, Mocanu MM, Carr RD, Brand CL, Yellon DM. Glucagon-like peptide 1 can directly protect the heart against ischemia\/reperfusion injury. Diabetes 2005;54:146\u201351.","journal-title":"Diabetes"},{"key":"6035_CR11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/sj.bjp.0706834","volume":"149","author":"CCT Smith","year":"2006","unstructured":"Smith CCT, Mocanu MM, Davidson SM, Wynne AM, Simpkin JC, Yellon DM. Leptin, the obesity-associated hormone, exhibits direct cardioprotective activity. Br J Pharmacol 2006;149:5\u201313.","journal-title":"Br J Pharmacol"},{"key":"6035_CR12","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","volume":"1","author":"A Degterev","year":"2005","unstructured":"Degterev A, Huang Z, Boyce M, Li Y, Jagtap P, Mizushima N, et al. Chemical inhibitor of non apoptotic cell death with therapeutic potential for ischemic brain injury. Nature Chem Biol 2005;1:112\u20139.","journal-title":"Nature Chem Biol"},{"key":"6035_CR13","doi-asserted-by":"crossref","first-page":"33635","DOI":"10.1074\/jbc.M606339200","volume":"281","author":"L Bao","year":"2006","unstructured":"Bao L, Li Y, Deng S-X, Landry D, Tabas I. Sitosterol-containing lipoproteins trigger free sterol-induced caspase-independent death in ACAT-competent macrophages. J Biol Chem 2006;281:33635\u201349.","journal-title":"J Biol Chem"},{"key":"6035_CR14","first-page":"3","volume":"55","author":"M Kukan","year":"2004","unstructured":"Kukan M. Emerging roles of proteasomes in ischemia-reperfusion injury of organs. J Physiol Pharmacol 2004;55:3\u201315.","journal-title":"J Physiol Pharmacol"},{"key":"6035_CR15","doi-asserted-by":"crossref","first-page":"H841","DOI":"10.1152\/ajpheart.00678.2003","volume":"287","author":"DJ Hausenloy","year":"2004","unstructured":"Hausenloy DJ, Yellon DM, Mani-Babu S, Duchen MR. Preconditioning protects by inhibiting the mitochondrial permeability transition. Am J Physiol Heart Circ Physiol 2004;287:H841\u20139.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"6035_CR16","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1242\/jcs.115.6.1175","volume":"115","author":"J Jacobson","year":"2002","unstructured":"Jacobson J, Duchen MR. Mitochondrial oxidative stress and cell death in astrocytes\u2014requirement for stored Ca2+ and sustained opening of the permeability transition pore. J Cell Sci 2002;115:1175\u201388.","journal-title":"J Cell Sci"},{"key":"6035_CR17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1023\/A:1006859011722","volume":"186","author":"MS Sumeray","year":"1998","unstructured":"Sumeray MS, Yellon DM. Characterisation and validation of a murine model of global ischaemia-reperfusion injury. Mol Cell Biochem 1998;186:61\u20138.","journal-title":"Mol Cell Biochem"},{"key":"6035_CR18","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1172\/JCI117815","volume":"95","author":"MS Marber","year":"1995","unstructured":"Marber MS, Mestril R, Chi SH, Sayen MR, Yellon DM, Dillman WH. Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischaemic injury. J Clin Invest 1995;95:1446\u201356.","journal-title":"J Clin Invest"},{"key":"6035_CR19","first-page":"858","volume":"38","author":"SY Lim","year":"2005","unstructured":"Lim SY, Wainwright CL, Kennedy S, Kane KA. Activation of protease-activated receptor-2 (PAR-2) induces cardioprotection in anaesthetised mice. J Mol Cell Cardiol 2005;38:858.","journal-title":"J Mol Cell Cardiol"},{"key":"6035_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/(SICI)1097-4652(200001)182:1<41::AID-JCP5>3.0.CO;2-7","volume":"182","author":"L Formigli","year":"2000","unstructured":"Formigli L, Papucci L, Tani A, Schiavone N, Tempestini A, Orlandini GE, et al. Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis. J Cell Physiol 2000;182:41\u20139.","journal-title":"J Cell Physiol"},{"key":"6035_CR21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.bjp.0703336","volume":"130","author":"MM Mocanu","year":"2000","unstructured":"Mocanu MM, Baxter GF, Yellon DM. Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury. Br J Pharmacol 2000;130:197\u2013200.","journal-title":"Br J Pharmacol"},{"key":"6035_CR22","doi-asserted-by":"crossref","first-page":"5039","DOI":"10.1016\/j.bmcl.2005.07.077","volume":"15","author":"X Teng","year":"2005","unstructured":"Teng X, Degterev A, Jagatap P, Xing X, Choi S, Denu R, et al. Structure-activity relationship study of novel necroptosis inhibitors. Bioorg Med Chem Lett 2005;15:5039\u201344.","journal-title":"Bioorg Med Chem Lett"},{"key":"6035_CR23","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0008-6363(02)00442-X","volume":"55","author":"ZQ Zhao","year":"2002","unstructured":"Zhao ZQ, Vinten-Johansen J. Myocardial apoptosis and ischemic preconditioning. Cardiovasc Res 2002;55:438\u201355.","journal-title":"Cardiovasc Res"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-007-6035-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-007-6035-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-007-6035-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T19:38:27Z","timestamp":1629488307000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-007-6035-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,31]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,9,10]]}},"alternative-id":["6035"],"URL":"https:\/\/doi.org\/10.1007\/s10557-007-6035-1","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,31]]}}}